Short description
Cellectar Biosciences is a pharmaceutical research company specializing in cancer drugs.
Description
Cellectar Biosciences, a radiopharmaceutical company, designs and develops products to detect, treat, and monitor various human cancers. Its products include 131I-CLR1404, a compound for cancer therapy. The company's product candidates combine lipid-like molecules and phospholipid ethers analogs with radioisotopes to image or destroy malignant cells.
Cellectar Biosciences was formerly known as Cellectar, LLC and changed its name in 2008. The company was founded in 2003 and is based in Madison, Wisconsin.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Madison, Wisconsin, United States, North America
Founded on
January 1, 2002
Exited on
January 11, 2013
Went public on
January 11, 2013
Stock symbol
CLRB
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Noaccessforu, Noaccess, Nopepepe, No Way, Noaccessforu, No Way, Nopepepe, No Way, No Way, Cannot Access
Sign in for full access
Founders
Jamey Weichert